Citations to this article
Abstract
Little is known about the role of IL-3 in multiple sclerosis (MS) in humans and in experimental autoimmune encephalomyelitis (EAE). Using myelin oligodendrocyte glycoprotein (MOG) peptide–induced EAE, we show that CD4+ T cells are the main source of IL-3 and that cerebral IL-3 expression correlates with the influx of T cells into the brain. Blockade of IL-3 with monoclonal antibodies, analysis of IL-3 deficient mice, and adoptive transfer of leukocytes demonstrate that IL-3 plays an important role for development of clinical symptoms of EAE, for migration of leukocytes into the brain, and for cerebral expression of adhesion molecules and chemokines. In contrast, injection of recombinant IL-3 exacerbates EAE symptoms and cerebral inflammation. In patients with relapsing-remitting MS (RRMS), IL-3 expression by T cells is markedly upregulated during episodes of relapse. Our data indicate that IL-3 plays an important role in EAE and may represent a new target for treatment of MS.
Authors
Kerstin Renner, Sonja Hellerbrand, Fabian Hermann, Christine Riedhammer, Yvonne Talke, Gabriela Schiechl, Manuel Rodriguez Gomez, Simone Kutzi, Dagmar Halbritter, Nicole Goebel, Hilke Brühl, Robert Weissert, Matthias Mack
Total citations by year
Citation information
Citations to this article (31)
| Title and authors | Publication | Year |
|---|---|---|
|
RiboTag-based RNA profiling uncovers oligodendroglial lineage-specific inflammation in autoimmune encephalomyelitis: implications for pathogenesis.
Wang Y, Ghimire S, Mangalam A, Kang Z |
Journal of neuroinflammation | 2025 |
|
Anti-LGI1 encephalitis and co-existence of MOG-IgG: a case report and literature review.
Ci X, Lin L, Wu Y, Ma Y, Lu J |
Frontiers in human neuroscience | 2025 |
|
IL-3: key orchestrator of inflammation
Podolska MJ, Grützmann R, Pilarsky C, Bénard A |
Frontiers in immunology | 2024 |
|
Infiltration by monocytes of the central nervous system and its role in multiple sclerosis: reflections on therapeutic strategies
Zhang G, Yao Q, Long C, Yi P, Song J, Wu L, Wan W, Rao X, Lin Y, Wei G, Ying J, Hua F |
Neural Regeneration Research | 2024 |
|
Selected Interleukins Relevant to Multiple Sclerosis: New Directions, Potential Targets and Therapeutic Perspectives
Mado H, Stasiniewicz A, Adamczyk-Sowa M, Sowa P |
International Journal of Molecular Sciences | 2024 |
|
Interleukin‐3 Modulates Macrophage Phagocytic Activity and Promotes Spinal Cord Injury Repair
Li J, Zheng M, Ouyang F, Ye J, Huang J, Zhao Y, Wang J, Shan F, Li Z, Yu S, Yao F, Tian D, Cheng L, Jing J |
CNS Neuroscience & Therapeutics | 2024 |
|
Interleukin-3 protects against viral pneumonia in sepsis by enhancing plasmacytoid dendritic cell recruitment into the lungs and T cell priming
Bénard A, Hansen FJ, Uhle F, Klösch B, Czubayko F, Mittelstädt A, Jacobsen A, David P, Podolska MJ, Anthuber A, Swierzy I, Schaack D, Mühl-Zürbes P, Steinkasserer A, Weyand M, Weigand MA, Brenner T, Krautz C, Grützmann R, Weber GF |
Frontiers in immunology | 2023 |
|
Basophils beyond allergic and parasitic diseases
Poto R, Loffredo S, Marone G, Di Salvatore A, de Paulis A, Schroeder JT, Varricchi G |
Frontiers in immunology | 2023 |
|
Interleukin-3 coordinates glial–peripheral immune crosstalk to incite multiple sclerosis
Kiss MG, Mindur JE, Yates AG, Lee D, Fullard JF, Anzai A, Poller WC, Christie KA, Iwamoto Y, Roudko V, Downey J, Chan CT, Huynh P, Janssen H, Ntranos A, Hoffmann JD, Jacob W, Goswami S, Singh S, Leppert D, Kuhle J, Kim-Schulze S, Nahrendorf M, Kleinstiver BP, Probert F, Roussos P, Swirski FK, McAlpine CS |
Immunity | 2023 |
|
IL-3 receptor signalling suppresses chronic intestinal inflammation by controlling mechanobiology and tissue egress of regulatory T cells
Ullrich KA, Derdau J, Baltes C, Battistella A, Rosso G, Uderhardt S, Schulze LL, Liu LJ, Dedden M, Spocinska M, Kainka L, Kubánková M, Müller TM, Schmidt NM, Becker E, Ben Brahim O, Atreya I, Finotto S, Prots I, Wirtz S, Weigmann B, López-Posadas R, Atreya R, Ekici AB, Lautenschläger F, Guck J, Neurath MF, Zundler S |
Gut | 2023 |
|
Amelioration of experimental autoimmune encephalomyelitis by in vivo reprogramming of macrophages using pro-resolving factors.
Gauthier T, Martin-Rodriguez O, Chagué C, Daoui A, Ceroi A, Varin A, Bonnefoy F, Valmary-Degano S, Couturier M, Behlke S, Saas P, Cartron PF, Perruche S |
Journal of Neuroinflammation | 2023 |
|
Serum Cytokines Predict Neurological Damage in Genetically Diverse Mouse Models
Pérez Gómez AA, Karmakar M, Carroll RJ, Lawley KS, Amstalden K, Young CR, Threadgill DW, Welsh CJ, Brinkmeyer-Langford C |
Cells | 2022 |
|
The roles of microglia and astrocytes in phagocytosis and myelination: Insights from the cuprizone model of multiple sclerosis.
Sen MK, Mahns DA, Coorssen JR, Shortland PJ |
Glia | 2022 |
|
The Role of CD4(+) T Cells in the Immunotherapy of Brain Disease by Secreting Different Cytokines.
Wang J, Nan Y, Liu M, Hu K |
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology | 2022 |
|
Interleukin-3 is associated with sTREM2 and mediates the correlation between amyloid-β and tau pathology in Alzheimer's disease.
Wang ZB, Ma YH, Sun Y, Tan L, Wang HF, Yu JT |
Journal of Neuroinflammation | 2022 |
|
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections
A Bénard, A Jacobsen, M Brunner, C Krautz, B Klösch, I Swierzy, E Naschberger, MJ Podolska, D Kouhestani, P David, T Birkholz, I Castellanos, D Trufa, H Sirbu, M Vetter, AE Kremer, K Hildner, A Hecker, F Edinger, M Tenbusch, P Mühl-Zürbes, A Steinkasserer, E Richter, H Streeck, MM Berger, T Brenner, MA Weigand, FK Swirski, G Schett, R Grützmann, GF Weber |
Nature Communications | 2021 |
|
Cytokines and Soluble HLA-G Levels in the Acute and Recovery Phases of Arbovirus-Infected Brazilian Patients Exhibiting Neurological Complications
RS Almeida, ML Ferreira, P Sonon, MT Cordeiro, I Sadissou, GT Diniz, M de Fátima Pessoa Militão-Albuquerque, RF Franca, EA Donadi, N Lucena-Silva |
Frontiers in immunology | 2021 |
|
Astrocytic interleukin-3 programs microglia and limits Alzheimer’s disease
CS McAlpine, J Park, A Griciuc, E Kim, SH Choi, Y Iwamoto, MG Kiss, KA Christie, C Vinegoni, WC Poller, JE Mindur, CT Chan, S He, H Janssen, LP Wong, J Downey, S Singh, A Anzai, F Kahles, M Jorfi, PF Feruglio, RI Sadreyev, R Weissleder, BP Kleinstiver, M Nahrendorf, RE Tanzi, FK Swirski |
Nature | 2021 |
|
NFIL3 deficiency alleviates EAE through regulating different immune cell subsets
Chen Z, Fan R, Liang J, Xiao Z, Dang J, Zhao J, Weng R, Zhu C, Zheng SG, Jiang Y |
Journal of Advanced Research | 2021 |
|
The RNFT2/IL3Rα Axis Regulates IL3 Signaling and Innate Immunity
Yao Tong, TRAVIS B. LEAR, John Evankovich, Yanwen Chen, James D Londino, Mike Myerburg, Yingze Zhang, Iulia Popescu, John F. McDyer, Bryan J. McVerry, Karina C. Lockwood, Michael J. Jurczak, Yuan Liu, Bill Chen |
JCI Insight | 2020 |
|
Increases in compulsivity, inflammation, and neural injury in HIV transgenic rats with escalated methamphetamine self-administration under extended-access conditions
G de Guglielmo, Y Fu, J Chen, E Larrosa, I Hoang, T Kawamura, I Lorrai, B Zorman, J Bryant, O George, P Sumazin, C Lefebvre, V Repunte-Canonigo, PP Sanna |
Brain Research | 2020 |
|
Single Cell Transcriptomics Implicate Novel Monocyte and T Cell Immune Dysregulation in Sarcoidosis
L Garman, RC Pelikan, A Rasmussen, CA Lareau, KA Savoy, US Deshmukh, H Bagavant, AM Levin, S Daouk, WP Drake, CG Montgomery |
Frontiers in immunology | 2020 |
|
The Poststroke Peripheral Immune Response Is Differentially Regulated by Leukemia Inhibitory Factor in Aged Male and Female Rodents
SM Davis, LA Collier, SJ Messmer, KR Pennypacker, JH Zhang |
Oxidative Medicine & Cellular Longevity | 2020 |
|
Self-reactive CD4 + IL-3 + T cells amplify autoimmune inflammation in myocarditis by inciting monocyte chemotaxis
A Anzai, JE Mindur, L Halle, S Sano, JL Choi, S He, CS McAlpine, CT Chan, F Kahles, C Valet, AM Fenn, M Nairz, S Rattik, Y Iwamoto, DL Fairweather, K Walsh, P Libby, M Nahrendorf, FK Swirski |
Journal of Experimental Medicine | 2019 |
|
Innate Immune Modulation by GM-CSF and IL-3 in Health and Disease
F Borriello, M Galdiero, G Varricchi, S Loffredo, G Spadaro, G Marone |
International journal of molecular sciences | 2019 |
|
Generation of IL-3–Secreting CD4 + T Cells by Microbial Challenge at Skin and Mucosal Barriers
S Kunnath-Velayudhan, MF Goldberg, NK Saini, TW Ng, P Arora, CT Johndrow, NA Saavedra-Avila, AJ Johnson, J Xu, J Kim, N Khajoueinejad, CD Petro, BC Herold, G Lauvau, J Chan, WR Jacobs, SA Porcelli |
ImmunoHorizons | 2019 |
|
Regulation of Lymphatic GM-CSF Expression by the E3 Ubiquitin Ligase Cbl-b
S Peer, G Cappellano, N Hermann-Kleiter, K Albrecht-Schgoer, R Hinterleitner, G Baier, T Gruber |
Frontiers in immunology | 2018 |
|
A systems medicine approach reveals disordered immune system and lipid metabolism in multiple sclerosis patients: Therapeutic targets in multiple sclerosis
M Pazhouhandeh, MA Sahraian, SD Siadat, A Fateh, F Vaziri, F Tabrizi, F Ajorloo, AK Arshadi, E Fatemi, SP Gavgani, F Mahboudi, FR Jamnani |
Clinical & Experimental Immunology | 2018 |
|
Regulatory role of oligodendrocyte gap junctions in inflammatory demyelination
CP Papaneophytou, E Georgiou, C Karaiskos, I Sargiannidou, K Markoullis, MM Freidin, CK Abrams, KA Kleopa |
Glia | 2018 |
|
IL-3 Is a Marker of Encephalitogenic T Cells, but Not Essential for CNS Autoimmunity
PW Lee, MK Xin, W Pei, Y Yang, AE Lovett-Racke |
Frontiers in immunology | 2018 |
|
Transcriptome Analysis of Mycobacteria-Specific CD4 + T Cells Identified by Activation-Induced Expression of CD154
S Kunnath-Velayudhan, MF Goldberg, NK Saini, CT Johndrow, TW Ng, AJ Johnson, J Xu, J Chan, WR Jacobs, SA Porcelli |
Journal of immunology (Baltimore, Md. : 1950) | 2017 |
